Here are five opportunities for growth in GI that Mel Ona, MD, president and founder of Ohana Endoscopy Center in Lapolei, Hawaii, and Shaibal Mazumdar, MD, a gastroenterologist at Aurora Advocate in ...
(NASDAQ:COSM), a global healthcare group, has announced the commencement of the development phase for CCDL24, a novel treatment for gastrointestinal (GI) disorders. CCDL24 utilizes advanced ...
A functional GI disorder, IBS is characterized by symptoms like bloating, gas, abdominal pain, cramping, constipation, and/or diarrhea. The syndrome is more common among women—affecting more ...
a novel treatment for gastrointestinal (GI) disorders. CCDL24 utilizes advanced biopolymeric grids made from natural ingredients to encapsulate bioactive molecules, aiming to extend their activity ...
SOLANA BEACH, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases ...